Sales Nexus CRM

Earth Science Tech Reports 57% Jump in Quarterly Net Income, Strengthens Balance Sheet

By Advos
Earth Science Tech's fiscal first-quarter net income surged 57% year-over-year, signaling robust growth in its healthcare platform and improved financial health.
Earth Science Tech Reports 57% Jump in Quarterly Net Income, Strengthens Balance Sheet

Earth Science Tech, Inc. (OTC: ETST) announced fiscal first-quarter 2027 results showing a 57% year-over-year increase in net income, reaching $715,697. The company's revenue rose 3% to $9.0 million, while gross profit climbed to $6.3 million. Operating cash flow more than doubled to $707,131, and total assets grew to $10.4 million. Diluted earnings per share improved to $0.003 from $0.001 in the prior-year period.

The company also repurchased and retired over 3.7 million common shares during the quarter without taking on additional debt, reflecting a commitment to enhancing shareholder value. According to the press release, all key operating subsidiaries remained profitable, and the company continues to expand the licensing footprint of its compounding pharmacy operations across the United States. Additionally, management is evaluating opportunities to broaden its telehealth and pharmacy fulfillment platforms.

These results underscore the company's progress in building a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine, clinical support, and direct-to-patient fulfillment. The integration of these services aims to streamline patient care from consultation to delivery, a core part of the company's value proposition.

Investors will have the chance to hear more about the company's strategic initiatives at its annual shareholder meeting scheduled for Aug. 31, 2026. The agenda includes votes on proposals such as the cancellation of the company's Series B Preferred Stock and updates on a potential exchange uplisting. An uplisting could improve liquidity and market visibility, potentially benefiting shareholders.

The company's performance comes amid a broader trend of consolidation and vertical integration in the healthcare sector, as companies seek to control more of the patient journey. Earth Science Tech's focus on compounding pharmacies and telehealth positions it to capitalize on the growing demand for personalized medicine and remote healthcare services.

For more details, the full press release is available at https://ibn.fm/WHicW. The company's latest news and updates can be found in its newsroom at https://ibn.fm/ETST.

Advos

Advos

@advos